Get all your news in one place.
100's of premium titles.
One app.
Start reading
Evening Standard
Evening Standard
World
Tamara Davison

What is Jemperli? New drug could slow progression of womb cancer

A new drug thought to slow the progression of womb cancer is being made available to some patients treated by the NHS.

Marketed under the brand Jemperli, the medical community believes the drug can improve the life expectancy of women suffering from womb cancer. Up to 200 women may be eligible to receive the drug each year after the NHS began to make it available in UK hospitals this week.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.